Background Cancer is one of the greatest public health challenges worldwide, and we still
lack complementary approaches to significantly enhance the efficacy of standard anticancer�…

The Ketogenic Diet (KD) is a modality of treatment used since the 1920s as a treatment for
intractable epilepsy. It has been proposed as a dietary treatment that would produce similar�…

Ketogenic dietary therapies (KDTs) are established, effective nonpharmacologic treatments
for intractable childhood epilepsy. For many years KDTs were implemented differently�…

Currently available pharmacological treatment of epilepsy has limited effectiveness. In
epileptic patients, pharmacological treatment with available anticonvulsants leads to seizure�…

Dietary and metabolic therapies have been attempted in a wide variety of neurological
diseases, including epilepsy, headache, neurotrauma, Alzheimer disease, Parkinson�…

The ketogenic diet, originally developed for the treatment of epilepsy in non-responder
children, is spreading to be used in the treatment of many diseases, including Alzheimer's�…

AIM To investigate whether patients with refractory epilepsy and healthy infants differ in gut
microbiota (GM), and how ketogenic diet (KD) alters GM. METHODS A total of 14 epileptic�…

Despite the development of new antiepileptic drugs (AEDs),~ 20%–30% of people with
epilepsy remain refractory to treatment and are said to have drug-resistant epilepsy (DRE)�…

The prevalence of Alzheimer's disease, a chronic neurodegenerative condition, is
increasing as is the need for effective treatments and preventions. The underlying pathology�…

An increasing number of data demonstrate the utility of ketogenic diets in a variety of
metabolic diseases as obesity, metabolic syndrome, and diabetes. In regard to neurological�…